Boston Scientific Corporation
BSX Healthcare Medical Devices
Boston Scientific Corporation’s revenue for fiscal 2025 (year ended December 2025) was $20.1 billion, up 19.9% from fiscal 2024. In the quarter to June 2026, revenue grew 7.53%, EPS grew 14.8%, free cash flow grew 13.3% and total debt rose 8.95%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow BSX
Boston Scientific Corporation (BSX) Operating cash flow
Boston Scientific Corporation's operating cash flow for fiscal 2025 was $4.5B, up 32.0% from $3.4B in fiscal 2024. Over the twelve months to 30 June 2026 it was $4.5B. Over the past ten years it has ranged from $310.0M (fiscal 2018) to $4.5B (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 3 consecutive fiscal years. Boston Scientific Corporation ranks 4th of 149 Medical Devices companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $4.5B | 31.99% |
| FY2024 | $3.4B | 37.24% |
| FY2023 | $2.5B | 64.02% |
| FY2022 | $1.5B | (18.40%) |
| FY2021 | $1.9B | 24.01% |
| FY2020 | $1.5B | (17.86%) |
| FY2019 | $1.8B | 492.26% |
| FY2018 | $310.0M | (78.26%) |
| FY2017 | $1.4B | 20.64% |
| FY2016 | $1.2B | 71.06% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $1.5B | 323.56% |
| Mar 2026 | $348.0M | (74.49%) |
| Dec 2025 | $1.4B | 1.56% |
| Sep 2025 | $1.3B | 4.43% |
| 42 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| ABT Abbott Laboratories compare | $9.9B |
| MDT Medtronic PLC compare | $8.0B |
| SYK Stryker Corporation compare | $5.5B |
| BSX Boston Scientific Corporation | $4.5B |
| PHG Koninklijke Philips N.V. compare | $2.6B |
| GEHC GE HealthCare Technologies Inc. compare | $2.1B |
| DXCM DexCom, Inc. compare | $1.7B |
| EW Edwards Lifesciences Corporation compare | $1.7B |
| STE STERIS plc compare | $1.3B |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on BSX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement